국가: 영국
언어: 영어
출처: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hydrocortisone
Accord-UK Ltd
H02AB09
Hydrocortisone
20mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 5060032242149
Package leaflet: Information for the patient HYDROCORTONE® 10 MG AND 20 MG TABLETS (HYDROCORTISONE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. HYDROCORTONE TABLETS ARE A STEROID MEDICINE, prescribed for many different conditions, including serious illnesses. YOU NEED TO TAKE IT REGULARLY to get the maximum benefit. DON’T STOP TAKING THIS MEDICINE without talking to your doctor - you may need to reduce the dose gradually. HYDROCORTONE TABLETS CAN CAUSE SIDE EFFECTS IN SOME PEOPLE (read section 4: ‘Possible side effects’ below). Some problems such as mood changes (feeling depressed, or ‘high’), or stomach problems can happen straight away. If you feel unwell in any way, keep taking your tablets, but SEE YOUR DOCTOR STRAIGHT AWAY SOME SIDE EFFECTS ONLY HAPPEN AFTER WEEKS OR MONTHS. These include weakness of arms and legs, or developing a rounder face (read section 4: ‘Possible side effects’ for more information). IF YOU TAKE IT FOR MORE THAN 3 WEEKS, YOU WILL GET A BLUE ‘STEROID CARD’: always keep it with you and show it to any doctor or nurse treating you. KEEP AWAY FROM PEOPLE WHO HAVE CHICKEN-POX OR SHINGLE s, if you have never had them. They could affect you severely. If you do come into contact with chicken pox or shingles, SEE YOUR DOCTOR STRAIGHT AWAY. NOW READ THE REST OF THIS LEAFLET. It includes other important information on the safe and effective use of this medicine that might be especially important for you. WHAT IS IN THIS LEAFLET 1. WHAT HYDROCORTONE TABLETS ARE AND WHAT ARE THEY USED FO 전체 문서 읽기
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hydrocortisone 20mg Tablets Hydrocortone 20mg Tablets Hydrocortisone Accord 20mg Tablets Hitoden 20mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 20mg tablet: 20mg hydrocortisone Excipient with known effect Each tablet contains 182.7mg of lactose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets 20mg tablets: white, half-scored tablets, marked ‘HYD 20’. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Corticosteroid For use as replacement therapy in primary, secondary, or acute adrenocortical insufficiency. Pre-operatively, and during serious trauma or illness in patients with known adrenal insufficiency or doubtful adrenocortical reserve. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Dosage must be individualised according to the response of the individual patient. The lowest possible dosage should be used. Doses should be multiples of 10 (i.e. 10mg, 20mg, 30mg, etc.). Undesirable effects may be minimised by using the lowest effective dose for the minimum period and by administering the daily requirement as a single morning dose or whenever possible, as a single morning dose on alternate days. Frequent patient review is required to titrate the dose against disease activity. To avoid hypoadrenalism and/or a relapse of the underlying disease, it may be necessary to withdraw the drug gradually (see section 4.4). _REPLACEMENT THERAPY_ In chronic adrenocortical insufficiency, a dosage of 20 to 30mg a day is usually recommended, sometimes together with 4-6 g of sodium chloride or 50-300 micrograms of fludrocortisone daily. When immediate support is mandatory, one of the soluble adrenocortical hormone preparations (e.g. dexamethasone sodium phosphate), which may be effective within minutes after parenteral administration, can be life- saving. _ _ _Paediatric population_: In chronic adrenocortical insufficiency, the dosage should be approximately 0.4 to 0.8mg/kg/ 전체 문서 읽기